Shandong Buchang Pharmaceuticals Co Ltd
SSE:603858

Watchlist Manager
Shandong Buchang Pharmaceuticals Co Ltd Logo
Shandong Buchang Pharmaceuticals Co Ltd
SSE:603858
Watchlist
Price: 15.64 CNY -0.38% Market Closed
Market Cap: 16.5B CNY

Wall Street
Price Targets

Price Targets Summary
Shandong Buchang Pharmaceuticals Co Ltd

There are no price targets for Shandong Buchang Pharmaceuticals Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Shandong Buchang Pharmaceuticals Co Ltd Competitors:
Price Targets
ANCR
Animalcare Group PLC
39% Upside
RX
Biosyent Inc
8% Upside
002294
Shenzhen Salubris Pharmaceuticals Co Ltd
5% Downside
524731
Jenburkt Pharmaceuticals Ltd
23% Upside
PFE
Pfizer Inc
17% Upside
MVP
Medical Developments International Ltd
58% Upside
000756
Shandong Xinhua Pharmaceutical Co Ltd
27% Downside
600750
Jiang Zhong Pharmaceutical Co Ltd
25% Upside

Revenue
Forecast

Revenue Estimate
Shandong Buchang Pharmaceuticals Co Ltd

For the last 10 years the compound annual growth rate for Shandong Buchang Pharmaceuticals Co Ltd's revenue is 1%. The projected CAGR for the next 4 years is 8%.

1%
Past Growth
8%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Shandong Buchang Pharmaceuticals Co Ltd

Operating Income forecast
is not available for
Shandong Buchang Pharmaceuticals Co Ltd

Net Income
Forecast

Net Income Estimate
Shandong Buchang Pharmaceuticals Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shandong Buchang Pharmaceuticals Co Ltd's stock price target?
Not Available

Shandong Buchang Pharmaceuticals Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Shandong Buchang Pharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
8%

For the last 10 years the compound annual growth rate for Shandong Buchang Pharmaceuticals Co Ltd's revenue is 1%. The projected CAGR for the next 4 years is 8%.

Back to Top